105 related articles for article (PubMed ID: 1997005)
1. Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
Leeder JS; Dosch HM; Spielberg SP
Biochem Pharmacol; 1991 Feb; 41(4):567-74. PubMed ID: 1997005
[TBL] [Abstract][Full Text] [Related]
2. Cellular toxicity of sulfamethoxazole reactive metabolites--II. Inhibition of natural killer activity in human peripheral blood mononuclear cells.
Leeder JS; Nakhooda A; Spielberg SP; Dosch HM
Biochem Pharmacol; 1991 Feb; 41(4):575-83. PubMed ID: 1997006
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-based viability assay for studies of reactive drug intermediates.
Leeder JS; Dosch HM; Harper PA; Lam P; Spielberg SP
Anal Biochem; 1989 Mar; 177(2):364-72. PubMed ID: 2729556
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
[TBL] [Abstract][Full Text] [Related]
5. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
[TBL] [Abstract][Full Text] [Related]
6. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
[TBL] [Abstract][Full Text] [Related]
7. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
8. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
9. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.
Summan M; Cribb AE
Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161
[TBL] [Abstract][Full Text] [Related]
10. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs.
Cribb AE; Spielberg SP
Vet Res Commun; 1990; 14(3):241-52. PubMed ID: 2382408
[TBL] [Abstract][Full Text] [Related]
11. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
[TBL] [Abstract][Full Text] [Related]
12. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
[TBL] [Abstract][Full Text] [Related]
13. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
14. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
[TBL] [Abstract][Full Text] [Related]
15. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
Cribb AE; Spielberg SP; Griffin GP
Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat.
Cribb AE; McQuaid T; Renton KW
Biochem Pharmacol; 2001 Aug; 62(4):457-9. PubMed ID: 11448455
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells.
Adeyanju K; Bend JR; Rieder MJ; Dekaban GA
Virol J; 2018 May; 15(1):82. PubMed ID: 29743079
[TBL] [Abstract][Full Text] [Related]
18. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.
Vyas PM; Roychowdhury S; Woster PM; Svensson CK
Biochem Pharmacol; 2005 Jul; 70(2):275-86. PubMed ID: 15894292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
